15-min delayed · Sep 4, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 2 firms covering Ingevity Corp, 1 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $70.00 to $75.00, so the covering firms are broadly aligned. The average target of $72.50 sits 3% above the current $70.55. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.90 next quarter toward $6.01 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS2 ratings
Moderate Buy
Strong Buy00%
Buy150%
Hold150%
Sell00%
Strong Sell00%
Based on 2 analysts giving stock ratings to Ingevity Corp.
As of Sep, 1 of 2 firms rate NGVT a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
NGVT EPS & revenue forecast
EPS · NEXT QUARTER
$0.90
Range $0.68 – $1.08 · 3 analysts · +43% YoY
Next period, 3 analysts expect Ingevity Corp to earn $0.90 a share (range $0.68 – $1.08), versus $0.63 a year earlier. Full-year consensus is $5.24, growing to $6.01 the year after.
REVENUE · NEXT QUARTER
$242.9M
Range $233.0M – $252.9M · 3 analysts · -13% YoY
Revenue is expected to reach $242.9M (range $233.0M – $252.9M), -12.6% year-over-year. Full-year consensus is $1.1B, rising to $1.1B next year.
Top analysts covering Ingevity Corp
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on NGVT.
#1
John McNulty
BMO Capital · Rank #143
Buy
$70.00-0.8% to target
Overall win rate
46%
+ Follow
#2
Michael Sison
Wells Fargo · Rank #222
Hold
$75.00+6.3% to target
Overall win rate
45%
+ Follow
NGVT stock forecast FAQ
What is NGVT's average 12-month price target?+
The 2 analysts with a live target average $72.50 for Ingevity Corp over the next 12 months, ranging from a $75.00 high to a $70.00 low.
Is NGVT stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 2 analyst ratings, 1 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for NGVT?+
The Street-high target is $75.00 (Wells Fargo), and the Street-low is $70.00 (BMO Capital). The average of all 2 active targets is $72.50.
How many Wall Street analysts cover NGVT?+
2 analysts have an active rating on Ingevity Corp, and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering NGVT?+
Among analysts who currently cover NGVT, John McNulty of BMO Capital has the strongest overall Quantellect track record (Rank #143). Their current call is Buy with a $70.00 target.
What is Ingevity Corp's projected EPS for next quarter?+
The consensus estimate is $0.90 per share (range $0.68 – $1.08) across 3 analysts. Full-year EPS is projected at $5.24, rising to $6.01 the following year.
How much revenue is Ingevity Corp expected to report next quarter?+
Consensus revenue is $242.9M (range $233.0M – $252.9M). Full-year revenue is projected at $1.1B, growing to $1.1B next year.
Have analysts been upgrading or downgrading NGVT lately?+
As of Sep, 1 of 2 firms rate NGVT a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their NGVT calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
